Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

3',5'-diiodothyronine in health and disease: studies by a radioimmunoassay

Journal Article · · J. Clin. Endocrinol. Metab.; (United States)

An RIA has been developed for 3'5'-diiiodothyronine (3',5'-T/sub 2/) in unextracted serum. Interference in binding of radioactive 3',5'-T/sub 2/ to anti-3',5'-T/sub 2/ was minimized by using phosphate buffer and merthiolate. The detection threshold of the RIA was 2.5 ng/dl. Recovery of nonradioactive 3',5'-T/sub 2/ averaged 99%. T/sub 4/, T/sub 3/, and rT/sub 3/ cross-reacted with anti-3',5'-T/sub 2/ antibody 0.0025, < 0.0004, and 0.22%, respectively. The 3'-monoiodothyronine cross-reacted 1.7%. Mean serum 3',5'-T/sub 2/ concentrations in ng/dl were 2.4 in 53 normal subjects, 4.2 in 7 hypothyroid patients, 14.9 in 34 hyperthyroid patients, 13.5 in 25 patients with hepatic cirrhosis, and 14.3 in 31 newborns' cord blood serum. The values for the latter four groups were significantly different from normal. The serum 3',5'-T/sub 2/ concentration of 7.7 ng/dl in eight subjects in the third trimester of pregnancy did not differ from normal when serum T/sub 4/ and T/sub 3/ were elevated. Oral administration of 300 ..mu..g rT/sub 3/ to 9 normal subjects led to an increase in serum 3'5'-T/sub 2/ concentration of 45% at 1h. Total fasting in 3 obese subjects was associated with an increase in serum 3',5'-T/sub 2/ from 8.6 to 16.3 ng/dl at 6 to 8 days; rT/sub 3/ increased similarly, while T/sub 3/ decreased and T/sub 4/ did not change. Administration of dexamethasone to 4 hyperthyroid patients was associated with nearly parallel increases in serum 3',5'-T/sub 2/ and rT/sub 3/ and a decrease in T/sub 3/. The 3',5'-T/sub 2/ concentrations in amniotic fluids were 15.2 ng/dl at 15 to 20 weeks gestation and 5.8 ng/dl at 33 to 40 weeks. Pronase hydrolysates of 9 normal thyroid glands contained 350 ..mu..gT/sub 4/ and 0.24 ..mu..g 3',5'-T/sub 2//g wet wt. It was estimated that thyroidal secretion contributes < 1% of 3',5'-T/sub 2/ in serum of normal man.

Research Organization:
Univ. of California, Los Angeles
OSTI ID:
6009428
Journal Information:
J. Clin. Endocrinol. Metab.; (United States), Journal Name: J. Clin. Endocrinol. Metab.; (United States) Vol. 47:6; ISSN JCEMA
Country of Publication:
United States
Language:
English

Similar Records

3'-L-monoiodothyronine: development of a radioimmunoassay and demonstration of in vivo conversion from 3',5'-diiodothyronine. [/sup 125/I tracer technique]
Journal Article · Sun Dec 31 23:00:00 EST 1978 · J. Clin. Endocrinol. Metab.; (United States) · OSTI ID:6510682

Radioimmunoassay for measurement of 3,3'-L-diiodothyronine (T/sub 2/). [/sup 125/I]
Journal Article · Wed Sep 01 00:00:00 EDT 1976 · J. Clin. Endocrinol. Metab.; (United States) · OSTI ID:7248575

Radioimmunoassay for 3',5'-diiodothyronine. [/sup 125/I tracer technique]
Journal Article · Tue Oct 31 23:00:00 EST 1978 · J. Clin. Endocrinol. Metab.; (United States) · OSTI ID:6542675